Anixa Biosciences Inc

ANIXNASDAQ · USD
2.67USD0.00 (+4.71%)
225

Anixa Biosciences Inc (ANIX) Historical Volatility

ANIX's 30 day historical volatility is 74.35%, in the 82nd percentile of readings over the past year. This is a high percentile, meaning Anixa Biosciences Inc shares have swung far more than usual. ANIX's 30 day implied volatility sits at 463.37%, with an IV Rank of 95.63%, leaving IV 389.02 points above historical volatility. This means options are pricing in more movement than the stock has actually delivered, as of Nov 17, 2026.

Read more

Tracking ANIX historical volatility helps you see how much Anixa Biosciences Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, ANIX's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor ANIX 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. ANIX's 30 day historical volatility, or ANIX HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing ANIX's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer.

Historical Volatility

HV Percentile
82ndHV Percentile
High

Historical movement is elevated versus the past year. The stock has been unusually active.

Historical Volatility (30d)74.35%

HV Percentile82nd

Implied Volatility (30d)463.37%

IV Rank95.63%

IV Minus HV+389.02%

As of Nov 17, 2026

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of Nov 17, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of Nov 17, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →